Abstract
Tay-Sachs disease is a lethal lysosomal storage disorder caused by mutations in the HexA gene encoding the α subunit of the lysosomal β-hexosaminidase enzyme (HEXA). Abnormal GM2 ganglioside accumulation causes progressive deterioration in the central nervous system in Tay-Sachs patients. Hexa-/- mouse model failed to display abnormal phenotype. Recently, our group generated Hexa-/-Neu3-/- mouse showed severe neuropathological indications similar to Tay-Sachs patients. Despite excessive GM2 ganglioside accumulation in the brain and visceral organs, the regulation of autophagy has not been clarified yet in the Tay-Sachs disease mouse model. Therefore, we investigated distinct steps of autophagic flux using markers including LC3 and p62 in four different brain regions from the Hexa-/-Neu3-/- mice model of Tay-Sachs disease. Our data revealed accumulated autophagosomes and autophagolysosomes indicating impairment in autophagic flux in the brain. We suggest that autophagy might be a new therapeutic target for the treatment of devastating Tay-Sachs disease.
Publisher
Public Library of Science (PLoS)
Reference36 articles.
1. The GM2 Gangliosidoses. In: The Online Metabolic and Molecular Bases of Inherited Diseases;RA Gravel;Internet],2014
2. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases;D Phaneuf;Human Molecular Genetics,1996
3. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease (animal model/GM2 gangliosidosis/homologous recombination/lysosomal storage disease);S Yamanaka;Medical Sciences [Internet],1994
4. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in a mouse model of Tay-Sachs disease;V Seyrantepe;Experimental Neurology,2018
5. GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early-onset Tay-Sachs disease;SA Demir;Journal of Neuroinflammation,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献